Rockefeller Capital Management
DICE

Rockefeller Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Rockefeller Capital Management’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34
Closed -$1K – 4137
2022
Q4 		$1K Hold
34
– – ﹤0.01% 3797
2022
Q3 		$0 Hold
34
– – ﹤0.01% 4532
2022
Q2 		$0 Buy
+34
New +$585 ﹤0.01% 4492

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Rockefeller Capital Management's DICE Position: Q1 2023 in Review

Rockefeller Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2023, closing a stake of 34 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in DICE in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q4 2022. 115 funds tracked by Wall St. Rank hold DICE as of Q1 2023.

  • Rockefeller Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 34 DICE Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1K.
  • Rockefeller Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Rockefeller Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.